|
Title
|
|
|
|
Phase
|
|
|
|
Protocol
IDs
|
|
|
|
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
|
|
|
|
Phase III
|
|
|
|
CAN-NCIC-MAP3
PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3
|
|
|
Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women
|
|
|
|
Phase III
|
|
|
|
UHM-CHS-4116
CHS 14116, NCT00513916
|
|
|
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
|
|
|
|
Phase III
|
|
|
|
IBCSG-35-07
IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, NCT00553410
|
|
|
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
|
|
|
|
Phase III
|
|
|
|
FNCLCC-ONCO-03/0701
FNCLCC-ONCO 03/0701 - LIBER, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, NCT00673335
|
|
|
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer
|
|
|
|
Phase III
|
|
|
|
ACCOG-HER-PCI
ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
|
|
|
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
|
|
|
|
Phase III
|
|
|
|
GD-10-08
NCT00808522
|
|
|
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
|
|
|
|
Phase II
|
|
|
|
CHNMC-IRB-02164
NCT00080756
|
|
|
Exemestane in Treating Postmenopausal Women at High Risk for Invasive Breast Cancer
|
|
|
|
Phase II
|
|
|
|
GUMC-2007-313
NCI-04-C-0044, NCT00085072, GUMC-2007-313, GT 07-313, 2007-313
|
|
|
Letrozole in Preventing Breast Cancer in Postmenopausal Women
|
|
|
|
Phase II
|
|
|
|
DFCI-00024
UCLA-0210012-02, NCT00090857
|
|
|
Soy Protein and Breast Cancer Risk Reduction
|
|
|
|
Phase II
|
|
|
|
02-422
Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477
|
|